Researchers: Strengthen restrictions on off-label promotion by pharmaceutical companies

Researchers are asking for tougher penalties and fines for pharmaceutical companies that market drugs for "off label" promotion, according to a study published in the October 28 issue of the open access journal PLoS Medicine.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news144397931.html">Researchers: Strengthen restrictions on off-label promotion by pharmaceutical companies</a></p> <p>Researchers are asking for tougher penalties and fines for pharmaceutical companies that market drugs for "off label" promotion, according to a study published in the October 28 issue of the open access journal <I>PLoS Medicine</I>.</p>